Peptide receptor radionuclide therapy (PRRT): clinical significance of re-treatment?

Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):1949-54. doi: 10.1007/s00259-015-3153-z.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Neuroendocrine Tumors / drug therapy
  • Octreotide / therapeutic use*
  • Radioimmunotherapy
  • Radioisotopes / therapeutic use
  • Receptors, Peptide / therapeutic use*

Substances

  • Radioisotopes
  • Receptors, Peptide
  • Octreotide